Hikma Pharmaceuticals PLC (GBP)
HIK
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range19.13 | 19.48
52-Wk Range15.40 | 22.12
Last Close19.28
Mkt Cap (m)4,670.89
Dividend yield1.76%
ISINGB00B0LCW083
Volume221,903
Exchange VenueLON

Company Profile

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Key Information
Price/Earning16.69
Price/Book3.28
Price/Sales2.82
P/CF13.94
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 22/01/2016
Annual Report
en 31/12/2018

Financials

Income Statement
GBP201420152016201720182019
Revenue (m)1,4891,4401,9501,9362,070-
Operating Income (m)402417363323378-
Net Income (m)278252155-843282-
Basic EPS1.401.270.67-3.511.17-
Avg. Diluted Shares Outstanding (m)200201234240242-
Balance Sheet
GBP201420152016201720182019
Current Assets (m)1,0131,3601,4481,5741,668-
Non Current Assets (m)1,2381,2372,9151,8141,829-
Total Assets (m)2,2512,5974,3633,3883,497-
Current Liabilities (m)841592918797893-
Total Liabilities (m)------
Total Equity (m)1,1971,3372,3961,5141,685-
Cash Flows
GBP201420152016201720182019
Operating Cash Flows (m)425366293443430-
Capital Expenditure (m)-118-137-190-151-139-
Figures are quoted in GBP unless stated otherwise
-
No change
£
19.28
Last Price